Schroder Ventures Life Sciences ("SVLS") have invested in the life sciences industry since the early 1980's and to date have backed over 100 life science companies internationally. SVLS was established in 1993 and currently has offices in Boston, London and San Francisco, which allows us to take advantage of the global nature of the life sciences opportunity. The SVLS team is comprised of 24 professionals, with extensive life sciences, venture capital investment, operational, scientific and clinical experience.
SVLS advises three private equity funds with total commitments of approximately $680m, focused on providing seed, start-up, early stage and expansion capital to life sciences companies primarily in the US and Europe. In addition, SVLS advises the International Biotechnology Trust (IBT) plc, a publicly quoted investment trust listed on the London Stock Exchange (IBT), with a total net asset value of approximately $56m (as at 30 June 2002).
Funds advised by SVLS are able to invest in all stages in the development of a life science business. SVLS provides hands-on scientific, advisory and financial support to its portfolio companies.
| Contact Details: |
| 71 Kingsway |
| London |
| |
| WC2B 6ST |
| United Kingdom |
| Tel: | +44 207 421 7070 |
| Fax: | 0207 421 7077 |
| Email: | jodie.vanelst@svlifesciences.com |
| WWW: | www.svlifesciences.com/
|
|
Loading...
|
Press Releases on Schroder Ventures Life Sciences:
|
 |
| Paul Capital Partners Promotes Ken Macleod To Partner |
24th July, 2008 |
Paul Capital Partners |
NEW YORK, July 24 /PRNewswire/ -- Paul Capital Partners today announced
that Ken Macleod, Ph.D., has been promoted to Partner. Based in Paul
Capital's London office, Dr. Macleod is
|
| International Biotechnology Trust plc (IBT) Strengthened by High Profile
|
1st December, 2004 |
International Biotechnology Trust |
International Biotechnology
Trust plc (IBT) Strengthened by High Profile Addition to the Investment
Management Team
June 1st 2005 –
International Biotechnology Trust plc (‘IBT’),
the
|
| PowderMed launched in spin out of powder injection DNA vaccine programmes
|
1st May, 2004 |
Powdermed |
PowderMed launched in spin out of powder injection DNA vaccine programmes from Chiron vaccines
PowderMed closes £20 million ($34.5 million; €30 million) financing and enhances deal with Glaxo
|
| SOLEXA APPOINTS DR SIMON BENNETT AS BUSINESS DEVELOPMENT DIRECTOR |
1st October, 2003 |
Solexa |
SOLEXA
APPOINTS DR SIMON BENNETT AS BUSINESS DEVELOPMENT DIRECTOR
1
October 2003, Little Chesterford, UK…Solexa,
the UK-based company
|
| Solexa appoints Clive G Brown as Head of Bioinformatics |
1st July, 2003 |
Solexa |
Solexa appoints Clive G
Brown as Head of Bioinformatics
4
July 2003, Little Chesterford, UK…Solexa,
the UK-based company developing a system that
|
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 391 times since April 2007, the link to the organisation's website has been followed 62 times
Recent Search Terms used to find this page: ken macleod sv life sciences | Schroder Ventures | schroder ventures | schroder venture capital | clive g. brown | Schroder Ventures International boston | schroder venture life sciences | schroder ventures life sciences | schroder life science | venture paul schroeder | .
Search for more companies in London
Search for more companies in
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Schroder Ventures Life Sciences
